Direct oral anticoagulant use and risk of perioperative bleeding: Evidence of absence or absence of evidence?

Willem M. Lijfering; Ynse I. G. V. Tichelaar

doi:10.1002/rth2.12084

Direct oral anticoagulant use and risk of perioperative bleeding: Evidence of absence or absence of evidence?

Willem M. Lijfering^*
, Ynse I. G. V. Tichelaar

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

8 Citations (Scopus)

263 Downloads (Pure)

Original language	English
Pages (from-to)	182-185
Number of pages	4
Journal	Research and practice in thrombosis and haemostasis
Volume	2
Issue number	2
DOIs	https://doi.org/10.1002/rth2.12084
Publication status	Published - Apr-2018

Keywords

anticoagulants
atrial fibrillation
hemorrhage
ATRIAL-FIBRILLATION
DABIGATRAN
MANAGEMENT
WARFARIN
INTERRUPTION
OUTCOMES
SURGERY

Access to Document

10.1002/rth2.12084Licence: CC BY-NC-ND

Direct oral anticoagulant use and risk of perioperative bleeding: Evidence of absence or absence of evidence?Final publisher's version, 242 KBLicence: CC BY-NC-ND

Handle.net

Persistent link

Cite this

@article{7eda5f2309cd45ee99747c7ffcaaeb3c,

title = "Direct oral anticoagulant use and risk of perioperative bleeding: Evidence of absence or absence of evidence?",

keywords = "anticoagulants, atrial fibrillation, hemorrhage, ATRIAL-FIBRILLATION, DABIGATRAN, MANAGEMENT, WARFARIN, INTERRUPTION, OUTCOMES, SURGERY",

author = "Lijfering, \{Willem M.\} and Tichelaar, \{Ynse I. G. V.\}",

year = "2018",

month = apr,

doi = "10.1002/rth2.12084",

language = "English",

volume = "2",

pages = "182--185",

journal = "Research and practice in thrombosis and haemostasis",

issn = "2475-0379",

publisher = "Wiley",

number = "2",

}

TY - JOUR

T1 - Direct oral anticoagulant use and risk of perioperative bleeding

T2 - Evidence of absence or absence of evidence?

AU - Lijfering, Willem M.

AU - Tichelaar, Ynse I. G. V.

PY - 2018/4

Y1 - 2018/4

KW - anticoagulants

KW - atrial fibrillation

KW - hemorrhage

KW - ATRIAL-FIBRILLATION

KW - DABIGATRAN

KW - MANAGEMENT

KW - WARFARIN

KW - INTERRUPTION

KW - OUTCOMES

KW - SURGERY

U2 - 10.1002/rth2.12084

DO - 10.1002/rth2.12084

M3 - Editorial

SN - 2475-0379

VL - 2

SP - 182

EP - 185

JO - Research and practice in thrombosis and haemostasis

JF - Research and practice in thrombosis and haemostasis

IS - 2

ER -